HITK Insider Trading Activity and SEC Form 4 Filings
HITK insider trading summary
No open-market insider purchases or sales of Hi Tech Pharmacal Co Inc (HITK) have been reported on SEC Form 4 in the past 12 months.
Latest HITK insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 13, 2013 | Gary M April | President, HCP Division | Sell | $296K (6,873 @ $43.06) |
| Oct 10, 2013 | Reuben Seltzer | Vice Chairman, Business Dev't | Sell | $485K (11,250 @ $43.13) |
| Oct 8, 2013 | David S Seltzer | CEO, President, Sec'y, Treas. | Sell | $991K (23,000 @ $43.09) |
| Oct 4, 2013 | Martin M Goldwyn | Director | Sell | $65K (1,500 @ $43.10) |
| Oct 3, 2013 | William J Peters | EVP & Chief Financial Officer | Sell | $916K (21,250 @ $43.11) |
| Oct 2, 2013 | Bruce W Simpson | Director | Sell | $436K (10,100 @ $43.14) |
| Oct 2, 2013 | Reuben Seltzer | Vice Chairman, Business Dev't | Sell | $485K (11,250 @ $43.13) |
| Oct 1, 2013 | Bruce W Simpson | Director | Sell | $663K (15,368 @ $43.15) |
| Sep 30, 2013 | Gary M April | President, HCP Division | Sell | $135K (3,125 @ $43.08) |
| Sep 27, 2013 | Martin M Goldwyn | Director | Sell | $129K (3,000 @ $43.10) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.